dc.contributor.author | Thorat, M | |
dc.contributor.author | Cuzick, J | |
dc.contributor.author | Jones, J | |
dc.contributor.author | Levey, P | |
dc.date.accessioned | 2021-08-02T16:47:15Z | |
dc.date.available | 2021-07-30 | |
dc.date.available | 2021-08-02T16:47:15Z | |
dc.identifier.citation | Thorat, Mangesh A et al. “Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial.” Clinical cancer research : an official journal of the American Association for Cancer Research, clincanres.1239.2021. 11 Aug. 2021, doi:10.1158/1078-0432.CCR-21-1239 | |
dc.identifier.issn | 1078-0432 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/73378 | |
dc.publisher | American Association for Cancer Research | en_US |
dc.relation.ispartof | Clinical Cancer Research | |
dc.title | Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial. | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1158/1078-0432.CCR-21-1239 | |
pubs.notes | Not known | en_US |
pubs.publication-status | Accepted | en_US |
pubs.publisher-url | https://doi.org/10.1158/1078-0432.CCR-21-1239 | |
dcterms.dateAccepted | 2021-07-30 | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |